Mary Territo

12.6k citations

110 papers · 10.0k indexed · 5 hit papers · h-index 45

Impact in

Biochemistry top 0.2%
- Antioxidant Activity and Oxidative Stress
Hematology top 0.2%
- Iron Metabolism and Disorders
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 43
- Hematopoietic Stem Cell Transplantation 27
- Acute Myeloid Leukemia Research 14
- Multiple Myeloma Research and Treatments 9
Immunology 37
- Atherosclerosis and Cardiovascular Diseases 14
- Immune Cell Function and Interaction 7

Co-authors: Alan M. Fogelman J A Berliner Gary J. Schiller Tomas Ganz Farhad Parhami Alan Lichtenstein Erika V. Valore Elizabeta Nemeth
Journals: Biology of Blood and Marrow Transplantation (10 papers)Blood (8 papers)Journal of Clinical Investigation (8 papers)Clinical Infectious Diseases (5 papers)British Journal of Haematology (5 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Mary Territo

108 papers receiving 9.6k citations

Hit Papers

5 papers align trajectories log scale

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein 2003 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Blood
1996 Arteriosclerosis Thrombosis and Vascular Biology
1990 Nature
1990 Proceedings of the National Academy of Sciences
1990 Journal of Clinical Investigation

Peers

Countries citing papers authored by Mary Territo

Since Specialization

Citations

This map shows the geographic impact of Mary Territo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Territo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Territo more than expected).

Fields of papers citing papers by Mary Territo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Territo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Territo. The network helps show where Mary Territo may publish in the future.

Co-authors

The 25 scholars most cited alongside Mary Territo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary Territo Line = papers co-authored together Mary Territo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Los Angeles County Journal of Medical Virology ·Theodoros Kelesidis, Romney M. Humphries, Dawn Terashita, Shahrooz Eshaghian, Mary Territo, Jonathan Said, Michael A. Lewinski, Judith S. Currier, David A. Pegues	2012	13
2	Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient Biology of Blood and Marrow Transplantation ·Patrick J. Stiff, Ivana N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, Daniel J. Weisdorf, Mary Territo, Karin Badel, Gary Calandra	2009	86
3	AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers” Biology of Blood and Marrow Transplantation ·Patrick J. Stiff, I.N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, N. Fromenberg, Daniel J. Weisdorf, Guido Tricot, Mary Territo, R. Abodnour, Karin Badel, Gary Calandra	2005	1
4	Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice Journal of Clinical Investigation ·Dennis Bruemmer, Alan R. Collins, Grace Noh, Wei Wang, Mary Territo, Sarah Arias-Magallona, Michael C. Fishbein, Florian Blaschke, Ulrich Kintscher, Kristof Graf, Ronald E. Law, Willa A. Hsueh	2003	246
5	Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation Clinical Infectious Diseases ·Drew J. Winston, Andrew M. Yeager, Pranatharthi Chandrasekar, David R. Snydman, Finn Bo Petersen, Mary Territo, (unknown)	2003	86
6	A Randomized Phase II Study of Amifostine Used As Stem Cell Protectant in Non-Hodgkin Lymphoma Patients Receiving Cisplatin-Based Salvage Chemotherapy Prior to Stem Cell Transplant Journal of Hematotherapy & Stem Cell Research ·Christos Emmanouilides, Mary Territo, Jeffrey Andrey, James R. Mason	2001	5
7	A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer The American Journal of Medicine ·Drew J. Winston, James W. Hathorn, Mindy G. Schuster, Gary J. Schiller, Mary Territo	2000	139
8	Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating β1 integrin Journal of Clinical Investigation ·Peggy T. Shih, Mariano J. Elices, Zhuang T. Fang, Tatiana P. Ugarova, D Strahl, Mary Territo, Joy S. Frank, Nicholas L. Kovach, Carlos Cabañas, Judith A. Berliner, Devendra K. Vora	1999	120
9	HTLV-I-associated myelopathy following allogeneic bone marrow transplantation Bone Marrow Transplantation ·CE Emmanouilides, Mary Territo	1999	6
10	Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission Leukemia ·Gary J. Schiller, M Lee, Timothy A. Miller, Michael Lill, Anuja Mittalhenkle, Ron Paquette, Charles L. Sawyers, Mary Territo	1997	18
11	Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver Liver Transplantation and Surgery ·Hugo R. Rosen, Paul Martin, Gary J. Schiller, Mary Territo, David Lewin, Christopher R. Shackleton, Ronald W. Busuttil	1996	35
12	Effect of Induction Cytarabine Dose Intensity on Long-Term Survival in Acute Myelogenous Leukemia: Results of a Randomized, Controlled Study Leukemia & lymphoma ·Gary J. Schiller, Stephen D. Nimer, James Gajewski, Myung Lee, Winston G. Ho, Mary Territo, R. Champlin	1993	4
13	Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. Journal of Clinical Investigation ·Farhad Parhami, Zhuang T. Fang, Alan M. Fogelman, Ali Andalibi, Mary Territo, J A Berliner	1993	217
14	Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. Journal of Clinical Oncology ·Gary J. Schiller, S D Nimer, Mary Territo, W. G. Ho, R. Champlin, James Gajewski	1992	56
15	Cyanotic congenital heart disease: Hematologic management Journal of the American College of Cardiology ·Mary Territo, Michael H. Rosove	1991	27
16	Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. Journal of Clinical Investigation ·J A Berliner, Mary Territo, Alex Sevanian, Sharifan Ramin, J A Kim, B Bamshad, M Esterson, Alan M. Fogelman Hit paper breakdown →	1990	784
17	Lipoprotein Receptors and Endothelial Cells Seminars in Thrombosis and Hemostasis ·Alan M. Fogelman, Judith A. Berliner, Brian Van Lenten, M. Navab, Mary Territo	1988	25
18	Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. Journal of Clinical Investigation ·H. Phillip Koeffler, Menashe Bar‐Eli, Mary Territo	1980	92
19	Familial Mediterranean fever. Recent advances in pathogenesis and management. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Arthur D. Schwabe, Paul I. Terasaki, Eugene V. Barnett, Mary Territo, James R. Klinenberg, Robert S. Peters	1977	27
20	Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA). Transplantation Proceedings ·Gale Rp, Stephen A. Feig, Gerhard Opelz, Mary Territo, Louise Young, Gregory Sarna, J. L. Fahey, Cline Mj	1976	12

About Mary Territo

Mary Territo is a scholar working on Hematology, Immunology, Genetics, Oncology and Immunology and Allergy, having authored 110 papers that have together received 10.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (14 papers), Atherosclerosis and Cardiovascular Diseases (14 papers), Lymphoma Diagnosis and Treatment (12 papers), Multiple Myeloma Research and Treatments (9 papers), Neutropenia and Cancer Infections (8 papers), Immune Cell Function and Interaction (7 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Biochemistry (1.4k citations), Hematology (2.2k citations), Immunology (3.3k citations), Immunology and Allergy (584 citations) and Genetics (983 citations). Mary Territo has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Alan M. Fogelman, J A Berliner, Gary J. Schiller, Tomas Ganz, Farhad Parhami, Alan Lichtenstein, Erika V. Valore, Elizabeta Nemeth, Judith A. Berliner and Mohamad Navab. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Journal of Clinical Investigation, Clinical Infectious Diseases and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact